Effect of Plum-blossom Needle vs. Tropicamide Eye Drops on Juvenile Myopia

March 24, 2017 updated by: Tang Lewei, Wenzhou Medical University

Effect of Plum-blossom Needle vs. Tropicamide Eye Drops on Juvenile Myopia: A Cross-over Single-blind Randomized Study

The purpose of this study is to determine whether plum-blossom needle is effective in the treatment of juvenile myopia and compare the efficacy with Tropicamide Eye Drops.

Study Overview

Status

Unknown

Conditions

Detailed Description

Plum-blossom needle is a historical treatment technology of Traditional Chinese Medicine, and has been applied to ophthalmic diseases, such as myopia and glaucoma, for nearly one hundred years.

Study Type

Interventional

Enrollment (Anticipated)

98

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zhejiang
      • Wenzhou, Zhejiang, China, 325027
        • Recruiting
        • School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The result of retinoscopy is myopic refractive error, near visual acuity and other visual functions must be normal
  • Distance visual acuity can be corrected to normal using negative spherical or cylindrical lenses
  • Myopia diopter spherical lenses must be ≤-3.00 D which measured under cycloplegia
  • Subjects must be between 8 and 20 years of age

Exclusion Criteria:

  • Diopter spherical lenses be >-3.00 D , or uncorrected distance visual acuity <0.1, or pathologic myopia with eye complications
  • Diopter spherical lense ≥1.50 D or cylindrical lenses ≥1.00 D, as measured under cycloplegia
  • The affected eyes have other diseases which affect the determination of acupuncture efficacy
  • Subjects with serious systemic diseases, such as cerebrovascular, liver, kidney, hematopoietic system, and psychiatric diseases
  • Longterm use of other related drugs or treatments, which have not been terminated
  • Parents or subjects refuse to participate this trial
  • Participating other ongoing clinical trials

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PbN-TED
Treated with plum-blossom needle first for 10 times during 20 days, followed with a one-month wash-out period and a 10-day period with Tropicamide Eye Drops.
  • acupoint selection: Zhengguang 1, Zhengguang 2, GB20, GV14, LI4.
  • plum-blossom needle manipulation methods: After the skin has been wiped with 75 % alcohol, plum-blossom needles will be tapped perpendicularly on the skin at the selected acupoints with wrist force and then lifted immediately. Each point will be tapped repeatedly for 20 to 50 times and both sides of cervical vertebra and temporal region, Suprao-infraorbital margin will be tapped repeatedly. Acupuncturists should tap the points gently to make patients feel only a little pain and stop when the skin gets flushed but is not bleeding.
Other Names:
  • Double head dermal needles (HWATO, China)
Instill one drop in both eyes every night before bed.
Other Names:
  • 6ml:30mg(0.5%)(FREDA, China)
Experimental: TED-PbN
Treated with Tropicamide Eye Drops for 10 days first, followed with a one-month wash-out period and 10 times of plum-blossom needle treatment for 20 days.
  • acupoint selection: Zhengguang 1, Zhengguang 2, GB20, GV14, LI4.
  • plum-blossom needle manipulation methods: After the skin has been wiped with 75 % alcohol, plum-blossom needles will be tapped perpendicularly on the skin at the selected acupoints with wrist force and then lifted immediately. Each point will be tapped repeatedly for 20 to 50 times and both sides of cervical vertebra and temporal region, Suprao-infraorbital margin will be tapped repeatedly. Acupuncturists should tap the points gently to make patients feel only a little pain and stop when the skin gets flushed but is not bleeding.
Other Names:
  • Double head dermal needles (HWATO, China)
Instill one drop in both eyes every night before bed.
Other Names:
  • 6ml:30mg(0.5%)(FREDA, China)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of vision acuity
Time Frame: Every 30 days for 150 days
International Standard Visual Acuity Chart
Every 30 days for 150 days
Changes of cycloplegic refractive errors
Time Frame: Every 30 days for 150 days
Measured using subjective refraction
Every 30 days for 150 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Changes of accommodation responses
Time Frame: Every 30 days for 150 days
Every 30 days for 150 days
Changes of accommodation facility
Time Frame: Every 30 days for 150 days
Every 30 days for 150 days
Changes of ciliary body thickness
Time Frame: Every 30 days for 150 days
Every 30 days for 150 days
Changes of axial length
Time Frame: Every 30 days for 150 days
Every 30 days for 150 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Yuanbo Liang, Doctor, Clinical&Epidemiological Eye Research Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (Anticipated)

January 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

March 20, 2017

First Submitted That Met QC Criteria

March 24, 2017

First Posted (Actual)

March 31, 2017

Study Record Updates

Last Update Posted (Actual)

March 31, 2017

Last Update Submitted That Met QC Criteria

March 24, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

The IPD sharing plan is undecided yet.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Plum-blossom Needle

Subscribe